首页 / 产品 / 蛋白 / 细胞因子、趋化因子与生长因子
| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | OCM |
| Uniprot No | P0CE72 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-109aa |
| 氨基酸序列 | MKHHHHHHASITDVLSADDIAAALQECRDPDTFEPQKFFQTSGLSKMSAN QVKDVFRFIDNDQSGYLDEEELKFFLQKFESGARELTESETKSLMAAADN DGDGKIGAEEFQEMVHS |
| 预测分子量 | 13 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3-4条关于OCM(假设为重组蛋白生产或应用相关领域)的虚构参考文献示例(实际文献需通过学术数据库查询)：
---
1. **文献名称**: *Optimized Expression and Purification of OCM Recombinant Protein in E. coli*
**作者**: Smith, J., et al.
**摘要**: 本研究通过优化大肠杆菌表达系统的启动子、诱导条件和培养基成分，显著提高了OCM重组蛋白的产量。纯化后蛋白活性验证表明其适用于体外酶活性分析。
2. **文献名称**: *Structural Characterization of OCM Protein and Its Role in Bone Regeneration*
**作者**: Li, X., & Wang, Y.
**摘要**: 利用X射线晶体学解析了OCM重组蛋白的三维结构，并发现其通过激活Wnt信号通路促进成骨细胞分化，为骨组织工程提供了潜在治疗分子。
3. **文献名称**: *OCM Recombinant Protein Enhances Immune Response in Cancer Therapy*
**作者**: Garcia, R., et al.
**摘要**: 在肿瘤模型中，OCM重组蛋白与PD-1抑制剂联用显著增强了T细胞抗肿瘤活性，表明其作为免疫治疗佐剂的潜力。
4. **文献名称**: *High-Yield Production of OCM in Pichia pastoris: A Cost-Effective Approach*
**作者**: Kim, S., et al.
**摘要**: 报道了在毕赤酵母中高效表达OCM重组蛋白的工艺，通过糖基化修饰提高了蛋白稳定性，为工业化生产提供了经济方案。
---
**注意**：以上文献为示例，实际研究中请通过 **PubMed**、**Google Scholar** 或 **Web of Science** 等平台，以关键词“OCM recombinant protein”或具体蛋白名称检索真实文献。
**Background of OCM Recombinant Protein**
Recombinant proteins, such as OCM, are engineered through genetic modification to express specific functional or structural traits in host organisms. OCM recombinant protein, while not universally standardized in nomenclature, often refers to proteins designed for biomedical research, therapeutic applications, or industrial processes. The term "OCM" may denote a specific protein variant, a proprietary formulation, or a target molecule linked to a particular pathway, such as osteogenic or metabolic regulation, depending on the context.
The development of recombinant proteins like OCM leverages technologies like codon optimization, plasmid design, and advanced expression systems (e.g., *E. coli*, yeast, or mammalian cells*) to enhance yield, stability, and bioactivity. For instance, if OCM is associated with bone metabolism (e.g., osteocalcin), its recombinant form might be produced to study osteoporosis or tissue regeneration. Alternatively, OCM could represent a cytokine, enzyme, or receptor critical in signaling pathways, aiding drug discovery or diagnostic assays.
Recombinant protein production addresses challenges in sourcing rare or human-derived proteins, offering scalability and reduced immunogenicity. OCM recombinant protein, like others in its class, undergoes rigorous purification (e.g., affinity chromatography) and validation (e.g., SDS-PAGE, Western blot) to ensure functionality. Its applications span therapeutics (e.g., monoclonal antibodies, vaccines), research tools (e.g., ELISA standards), and biomanufacturing (e.g., enzyme catalysts).
The significance of OCM recombinant protein lies in its versatility to mimic natural proteins while enabling customization—such as fusion tags for detection or enhanced solubility—making it indispensable in modern biotechnology and medicine. Ongoing advancements in synthetic biology and AI-driven protein design further expand its potential, driving innovation in personalized medicine and sustainable bioproduction.
(Word count: 249)
×
